Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Nutt
John G
JG
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D004386:Duodenum; D006801:Humans; D007260:Infusion Pumps; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D007980:Levodopa